|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...3637383940414243444546...110111» |
- Trial suspension: Pr (clinicaltrials.gov) - Nov 5, 2015
P=N/A, N=60, Suspended, Sponsor: Centre Hospitalier Universitaire de N?mes
Not yet recruiting --> Suspended
- Enrollment closed, Preclinical: Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy (clinicaltrials.gov) - Nov 5, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: Duke University
Not yet recruiting --> Suspended Recruiting --> Active, not recruiting
- Trial completion: Detection of Loco-regional Invasion of Cervical Cancer With 7 Tesla MRI (clinicaltrials.gov) - Nov 5, 2015
P=N/A, N=23, Completed, Sponsor: UMC Utrecht
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment change, Trial primary completion date: Autologous Mitochondrial Transfer in ICSI to Improve Oocyte and Embryo Quality in IVF Patients. Pilot Study (clinicaltrials.gov) - Nov 3, 2015
P=N/A, N=60, Recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Recruiting --> Completed N=30 --> 60 | Trial primary completion date: Mar 2016 --> Jul 2016
- |||||| Enrollment open: DESTINy: Diafert for Embryo Selection and Fertility Improvement (clinicaltrials.gov) - Nov 3, 2015
P3, N=180, Recruiting, Sponsor: Forest Laboratories
N=30 --> 60 | Trial primary completion date: Mar 2016 --> Jul 2016 Active, not recruiting --> Recruiting
- Enrollment open: Autologous Mitochondrial Transfer in ICSI to Improve Oocyte and Embryo Quality in IVF Patients. Pilot Study (clinicaltrials.gov) - Nov 3, 2015
P=N/A, N=60, Recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Active, not recruiting --> Recruiting Active, not recruiting --> Recruiting
- | New P4 trial: Laser - a New Possibility in Fertility Treatment - a Pilot Study (clinicaltrials.gov) - Nov 3, 2015
P4, N=270, Recruiting, Sponsor: Regionshospitalet Viborg, Skive
- New trial: Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®) (clinicaltrials.gov) - Nov 2, 2015
P=N/A, N=126, Recruiting, Sponsor: Clinical Research Centre, Malaysia
- |||||||||| New P3 trial: DESTINy: Diafert® for Embryo Selection and Fertility Improvement (clinicaltrials.gov) - Nov 2, 2015
P3, N=180, Recruiting, Sponsor: Forest Laboratories
- |||||||||| New P3 trial: Diafert for Embryo Selection and Fertility Improvement (DESTINy) (clinicaltrials.gov) - Nov 2, 2015
P3, N=180, Recruiting, Sponsor: Forest Laboratories
- Trial primary completion date: Accuracy of Endometrial Volume Measured by VOCAL Versus Office Hysteroscopy for Diagnosis of Endometrial Polyps (clinicaltrials.gov) - Nov 1, 2015
P=N/A, N=90, Recruiting, Sponsor: Ain Shams University
Active, not recruiting --> Recruiting Trial primary completion date: Oct 2015 --> Feb 2016
- Trial primary completion date: Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study (clinicaltrials.gov) - Nov 1, 2015
P=N/A, N=70, Recruiting, Sponsor: Ain Shams University
Trial primary completion date: Oct 2015 --> Feb 2016 Trial primary completion date: Jun 2015 --> Mar 2016
- Trial initiation date: Community-Driven Cervical Cancer Prevention in Western Kenya (clinicaltrials.gov) - Nov 1, 2015
P=N/A, N=7200, Not yet recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Jun 2015 --> Mar 2016 Initiation date: Feb 2015 --> Oct 2015
- metformin / Generic mfg.
Trial primary completion date: PregMet2: Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Oct 30, 2015
P=N/A, N=1000, Recruiting, Sponsor: Norwegian University of Science and Technology
Initiation date: Feb 2015 --> Oct 2015 Trial primary completion date: Sep 2015 --> Dec 2015
- navitoclax (ABT 263) / AbbVie
New P2 trial: MONAVI-1: A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer (clinicaltrials.gov) - Oct 29, 2015
P2, N=46, Not yet recruiting, Sponsor: Centre Francois Baclesse
- || Bravelle (urofollitropin) / Ferring
Trial primary completion date: Study of the Cleavage of the Egg in Relation to the Stimulation Treatment (clinicaltrials.gov) - Oct 29, 2015
P=N/A, N=600, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Mar 2016 --> Nov 2016
- Trial completion: Internet-based Study of Fertility and Early Pregnancy (PEEPS) (clinicaltrials.gov) - Oct 29, 2015
P=N/A, N=161, Completed, Sponsor: Courtney D.Lynch, PhD MPH
Trial primary completion date: Mar 2016 --> Nov 2016 Active, not recruiting --> Completed
- Trial completion: PALME: Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer (clinicaltrials.gov) - Oct 28, 2015
P=N/A, N=529, Completed, Sponsor: National Cancer Center, Korea
Active, not recruiting --> Completed Recruiting --> Completed
- New P1 trial: Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium (clinicaltrials.gov) - Oct 28, 2015
P1, N=10, Not yet recruiting, Sponsor: University of California, San Diego
- Enrollment closed: Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation (clinicaltrials.gov) - Oct 28, 2015
P=N/A, N=700, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Lynparza (olaparib) / Merck (MSD), AstraZeneca
Trial initiation date, Trial primary completion date, Monotherapy, BRCA Biomarker, PARP Biomarker: Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations (clinicaltrials.gov) - Oct 27, 2015
P3, N=167, Not yet recruiting, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting Initiation date: Jul 2015 --> Apr 2016 | Trial primary completion date: Apr 2018 --> Jan 2019
- ||| somatropin / Generic mfg.
Trial completion: GeNeSIS: Observational Study of Somatropin Treatment in Children (clinicaltrials.gov) - Oct 27, 2015
P=N/A, N=22929, Completed, Sponsor: Eli Lilly and Company
Initiation date: Jul 2015 --> Apr 2016 | Trial primary completion date: Apr 2018 --> Jan 2019 Active, not recruiting --> Completed
- New trial: Autologous Mitochondrial Transfer in ICSI to Improve Oocyte and Embryo Quality in IVF Patients. Pilot Study (clinicaltrials.gov) - Oct 26, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
- |||||||||| New P3 trial: DESTINy: Diafert for Embryo Selection and Fertility Improvement (clinicaltrials.gov) - Oct 26, 2015
P3, N=180, Active, not recruiting, Sponsor: Forest Laboratories
- diphenhydramine / Generic mfg.
Trial primary completion date: Effects of Intravenous Lidocaine on Endometriosis Pain (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=30, Recruiting, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Aug 2016
- Trial primary completion date: Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=160, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Trial primary completion date: Dec 2015 --> Aug 2016 Trial primary completion date: Dec 2014 --> Jan 2013
- |||| Trial primary completion date: Laparoscopic Approach to Cancer of the Endometrium (clinicaltrials.gov) - Oct 23, 2015
P3, N=640, Active, not recruiting, Sponsor: Queensland Centre for Gynaecological Cancer
Trial primary completion date: Dec 2014 --> Jan 2013 Trial primary completion date: Jan 2015 --> Apr 2016
- Enrollment change, Trial termination, Trial primary completion date, Metastases: Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer (clinicaltrials.gov) - Oct 23, 2015
P1, N=11, Terminated, Sponsor: UNC Lineberger Comprehensive Cancer Center
Trial primary completion date: Jan 2015 --> Apr 2016 N=34 --> 11 | Recruiting --> Terminated | Trial primary completion date: Jun 2014 --> May 2015; Unable to meet accrual due to changing practice patters
- emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
New trial, Discordant: PrEP-HIVD: Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=50, Not yet recruiting, Sponsor: University of Missouri-Columbia
- ||| Enrollment open: Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=200, Recruiting, Sponsor: Institute of Tropical Medicine, Belgium
N=34 --> 11 | Recruiting --> Terminated | Trial primary completion date: Jun 2014 --> May 2015; Unable to meet accrual due to changing practice patters Not yet recruiting --> Recruiting
- New trial: Reducing HIV Risk Among Adolescents: Evaluating Project HEART (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=150, Recruiting, Sponsor: North Carolina State University
- Enrollment open, Preclinical: Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=800, Recruiting, Sponsor: The University of Hong Kong
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial primary completion date: Fermented Wheat Germ Extract in Women With Ovarian Cancer (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Not yet recruiting --> Recruiting Trial primary completion date: Aug 2016 --> Dec 2016
- || anastrozole/levonorgestrel (BAY 98-7196) / Bayer
Trial primary completion date: Bay98-7196, Dose Finding / POC Study (clinicaltrials.gov) - Oct 22, 2015
P2b, N=318, Recruiting, Sponsor: Bayer
Trial primary completion date: Aug 2016 --> Dec 2016 Trial primary completion date: May 2016 --> Sep 2016
- Avastin (bevacizumab) / Roche
Trial primary completion date: Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=200, Recruiting, Sponsor: Hellenic Oncology Research Group
Trial primary completion date: May 2016 --> Sep 2016 Trial primary completion date: Mar 2015 --> Mar 2016
- |||| trebananib (AMG 386) / Amgen
Trial primary completion date, Combination therapy: TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer (clinicaltrials.gov) - Oct 22, 2015
P3, N=1015, Active, not recruiting, Sponsor: Amgen
Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Sep 2015 --> Dec 2015
- Arenegyr (NGR-hTNF) / AGC Biologics
Trial primary completion date, Combination therapy, Metastases: Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer (clinicaltrials.gov) - Oct 22, 2015
P2, N=37, Active, not recruiting, Sponsor: MolMed S.p.A.
Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Dec 2015 --> Jun 2016
- | OPB-111001 / Otsuka
Trial termination, Trial primary completion date, Metastases: A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer (clinicaltrials.gov) - Oct 22, 2015
P1/2, N=79, Terminated, Sponsor: Otsuka Novel Products GmbH
Trial primary completion date: Dec 2015 --> Jun 2016 Suspended --> Terminated | Trial primary completion date: Dec 2016 --> Feb 2015
- | Votrient (pazopanib) / Novartis, BeiGene
Trial initiation date, Trial primary completion date: Phase II Study of Pazopanib and Topotecan in Cervical Cancer (clinicaltrials.gov) - Oct 22, 2015
P2, N=40, Not yet recruiting, Sponsor: M.D. Anderson Cancer Center
Suspended --> Terminated | Trial primary completion date: Dec 2016 --> Feb 2015 Initiation date: Jul 2015 --> Feb 2016 | Trial primary completion date: Jul 2018 --> Feb 2019
- triptorelin / Generic mfg.
Trial initiation date: ENDOFIV: The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis (clinicaltrials.gov) - Oct 22, 2015
P4, N=200, Completed, Sponsor: Instituto de Investigacion Sanitaria La Fe
Initiation date: Jul 2015 --> Feb 2016 | Trial primary completion date: Jul 2018 --> Feb 2019 Initiation date: Sep 2011 --> Mar 2012
- |||| Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
Enrollment open: MEGASET HR: MENOPUR (clinicaltrials.gov) - Oct 22, 2015
P4, N=600, Recruiting, Sponsor: Ferring Pharmaceuticals
Initiation date: Sep 2011 --> Mar 2012 Not yet recruiting --> Recruiting
- New trial: MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=10, Not yet recruiting, Sponsor: Washington University School of Medicine
- ||||| CRS-207 / Novartis
New P2 trial, Combination therapy: SEASCAPE: Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer (clinicaltrials.gov) - Oct 22, 2015
P2, N=86, Not yet recruiting, Sponsor: Aduro BioTech, Inc.
- |||| fluconazole oral / Generic mfg.
Trial completion, Trial primary completion date: Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis (clinicaltrials.gov) - Oct 21, 2015
P4, N=240, Completed, Sponsor: Peking University Shenzhen Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: May 2015 --> Sep 2015
- ||| Trial completion, Enrollment change, Trial primary completion date: Eeva™ Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study (clinicaltrials.gov) - Oct 21, 2015
P=N/A, N=104, Completed, Sponsor: Progyny, Inc.
Recruiting --> Completed | Trial primary completion date: May 2015 --> Sep 2015 Active, not recruiting --> Completed | N=300 --> 104 | Trial primary completion date: Mar 2014 --> Jun 2015
- Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
Trial completion, Trial primary completion date: IVF/ICSI Protocols in Poor Responders With Growth Hormone (clinicaltrials.gov) - Oct 20, 2015
P4, N=287, Completed, Sponsor: Woman's Health University Hospital, Egypt
Active, not recruiting --> Completed | N=300 --> 104 | Trial primary completion date: Mar 2014 --> Jun 2015 Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Jan 2015
- | Avastin (bevacizumab) / Roche
Trial completion, Combination therapy: Irinotecan and Bevacizumab for Recurrent Ovarian Cancer (clinicaltrials.gov) - Oct 19, 2015
P2, N=29, Completed, Sponsor: New York University School of Medicine
Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Jan 2015 Active, not recruiting --> Completed
- gemcitabine / Generic mfg.
Trial completion, Metastases: Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients (clinicaltrials.gov) - Oct 16, 2015
P2, N=50, Completed, Sponsor: Professor Fernando Figueira Integral Medicine Institute
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: The Valve of Hyaluronic Binding Selection (PICSI) in Improving IVF Outcome (clinicaltrials.gov) - Oct 15, 2015
P=N/A, N=30, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
Recruiting --> Completed Active, not recruiting --> Completed | N=60 --> 30 | Trial primary completion date: Mar 2015 --> Jun 2014
- ||||||| Orilissa (elagolix) / AbbVie
Trial completion: A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain (clinicaltrials.gov) - Oct 15, 2015
P3, N=872, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Active, not recruiting --> Completed | N=60 --> 30 | Trial primary completion date: Mar 2015 --> Jun 2014 Active, not recruiting --> Completed